Mankind Pharma Completes Global Supply Chain Revamp

Mankind Pharma has completed a multi-year overhaul of its global supply chain and strategic procurement operations, strengthening medicine access, improving supply reliability, and preparing the business for disciplined growth.

The transformation, delivered with Accenture, introduces digitally enabled operating models powered by advanced analytics and AI across procurement, manufacturing, and distribution.

As India’s fourth-largest pharmaceutical company, Mankind Pharma has built an integrated, end-to-end backbone that connects planning with execution. A new integrated planning platform now links demand forecasting, manufacturing, inventory, and distribution across more than 25 international markets in near real time. This has improved forecast accuracy, strengthened cross-functional alignment, and enabled faster decision-making amid demand volatility, supply disruptions, and regulatory pressures.

Also Read: How Emerging Biotech Startups Reshaping the Bioprocessing Future

The customized platform spans 30 manufacturing plants and over 50 distribution centers worldwide. It has reduced drug stock-outs by 75 percent and optimized inventory levels by up to 20 percent across the company’s global network. The system has also improved coordination between commercial, manufacturing, and supply teams.

Alongside this, the company completed an 18-month transformation of its sourcing and procurement function. Standardized processes, clearer sourcing ownership, and digital automation now support stronger governance and cost discipline. Advanced analytics offer deeper visibility into spending, supplier performance, and supply chain risks.

Arjun Juneja, chief operating officer, Mankind Pharma Ltd., said: “Ensuring uninterrupted access to quality medicines today requires value chains that are intelligent, digitally enabled, and resilient by design. At Mankind, we have reimagined the traditional value chain into a life chain—built to serve patients, not just processes.”

Jignesh Vora, managing director and lead - life sciences, Accenture in India, said, “Working closely with Mankind Pharma, Accenture helped reimagine and strengthen the company’s operating model for the long term.”